Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, works through a gradual dose-escalation protocol that typically spans 16 to 20 weeks. This structured approach allows your body to adapt to the medication while steadily increasing its appetite-suppressing and metabolic effects. Understanding how dosing works helps you know what to expect on your weight loss journey.
How Semaglutide Dosing Works in Clinical Practice
Semaglutide is administered as a once-weekly subcutaneous injection that begins at a low starting point and increases every four weeks in a predictable pattern. The typical escalation sequence moves through four established levels, each chosen to build tolerance and reduce gastrointestinal side effects like nausea. Clinical trials showed that this gradual titration approach leads to better long-term adherence and sustained weight loss compared to rapid dose increases.
Your healthcare provider monitors your response at each step, assessing both weight reduction and tolerance. Some patients may stay at intermediate levels longer if they achieve their goals or experience side effects, while others progress to the highest therapeutic dose. The flexibility of dosing allows PlexusDx to personalize your treatment timeline based on your individual response.
The Four-Week Escalation Schedule Explained
The standard semaglutide titration begins at 0.25 mg once weekly for four weeks, establishing baseline tolerance and allowing your body to adjust to the medication's mechanism. After week four, the dose increases to 0.5 mg weekly, where most patients begin noticing appetite suppression and early weight changes. Weeks nine through twelve introduce a 1.0 mg dose, often considered the sweet spot for balanced efficacy and tolerability in many individuals.
The final escalation to 2.4 mg weekly occurs in weeks 13 through 16 and represents the maximum therapeutic dose used in Wegovy treatment protocols. This highest level is where most weight loss trials demonstrated the most significant metabolic benefits, with average losses of 15 to 22 percent of baseline body weight. However, reaching this dose is not mandatory—your progress and comfort determine whether advancement is appropriate for your situation.
What to Expect at Each Semaglutide Dose Level
During the initial 0.25 mg phase, most patients experience minimal side effects while their brain begins receiving satiety signals through GLP-1 receptor activation. Appetite reduction typically becomes noticeable by week two or three, and some individuals report modest weight loss even at this entry level. Energy levels usually remain stable, though a small percentage notice mild nausea that resolves within a few days of injection.
At the 0.5 mg dose, appetite suppression intensifies significantly, and most patients report eating smaller portions without conscious effort or hunger. This is where meaningful weight loss accelerates for many people, with weekly drops of 1 to 2 pounds becoming common. Gastrointestinal side effects like nausea or constipation may emerge at this level but typically improve as your body adapts over the following weeks.
The 1.0 mg dose deepens appetite reduction and enhances metabolic changes throughout your body, triggering continued weight loss momentum. Blood sugar control improves markedly at this level, and many patients feel sustained energy without the mid-afternoon crashes they experienced before treatment. Food aversions may develop, where previously enjoyed high-calorie foods become unappealing—a phenomenon driven by your altered brain chemistry.
Personalized Dosing With PlexusDx Genetic Insights
Every person's response to semaglutide is shaped by their unique genetic architecture, particularly variations in GLP-1 receptor genes and appetite-regulation pathways. PlexusDx Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761 and GIPR rs1800437, which influence how effectively your body responds to the medication. Understanding your genetic peptide profile allows PlexusDx to recommend a dosing timeline tailored specifically to your predicted response pattern.
Patients with genetic variants associated with higher GLP-1 sensitivity may achieve meaningful results at lower doses, while others with genetic patterns suggesting lower baseline receptor activity might benefit from faster progression to maintenance levels. This precision approach reduces unnecessary dose escalations and minimizes side effects by matching your medication strategy to your biology. The $99 Precision Peptide Genetic Test add-on, available after your first month of treatment, provides this personalization layer that standard Wegovy prescribing cannot offer.
Semaglutide Pricing and Access Through PlexusDx
PlexusDx compounded semaglutide injections start at $149 per month, regardless of which dose level you're currently using in your escalation schedule. Your dose may need to go up—your price won't. This flat-rate pricing structure eliminates the financial anxiety of dose progression and ensures you never face surprise cost increases as your treatment evolves.
All PlexusDx semaglutide comes from licensed 503A compounding pharmacies and serves all 50 states without requiring insurance or membership fees. Medications qualify for HSA and FSA reimbursement, further reducing out-of-pocket expenses for eligible patients. Three commitment tiers accommodate different preferences, with monthly flexibility or deeper discounts for longer commitments—allowing you to choose the financial structure that best supports your weight loss goals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I stop semaglutide escalation at a dose that's working for me?
Yes—dose progression is flexible and guided by your results and side effect tolerance. If you achieve meaningful weight loss and feel well at 1.0 mg or 1.7 mg, your PlexusDx provider can keep you at that maintenance dose indefinitely. The four-week escalation schedule is a framework, not a mandate.
How much weight loss should I expect at each semaglutide dose?
At 0.25–0.5 mg, most people lose 2–4 pounds weekly. By 1.0 mg, weekly loss often reaches 3–5 pounds. At the maximum 2.4 mg dose, clinical trials showed average total losses of 15–22 percent of baseline body weight over six months. Individual results vary based on diet, exercise, metabolism, and genetics.
Does PlexusDx charge more for higher semaglutide doses?
No. PlexusDx compounded semaglutide injections remain at $149 per month regardless of your current dose level. This flat pricing ensures your costs stay predictable as you progress through your treatment plan.
What if I experience side effects at a higher semaglutide dose?
Side effects like nausea or constipation typically resolve within days as your body adapts. If they persist, your PlexusDx provider can slow escalation, stay at your current dose longer, or adjust your diet and hydration strategy. You're never pressured to advance your dose if you're not ready.
How does the PlexusDx Precision Peptide Genetic Test help with semaglutide dosing?
The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways—markers that predict your individual medication response profile. Patients with high-sensitivity variants may see results faster, while others might benefit from extended time at intermediate doses. This genetic roadmap personalizes your escalation pace.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Do Some People Not Lose Weight on Wegovy?
Why Do Some People Not Lose Weight on Wegovy?